Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice
Maria A. Croyle, Ami Patel, Kaylie N. Tran et al. · 2008
Read Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice by Maria A. Croyle, Ami Patel, Kaylie N. Tran et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003548.txt.
Description
Maria A. Croyle and co-authors delivered a vaccine through the nose in this 2008 mouse study. Many people already have immunity to adenovirus type 5. That virus is a popular carrier for vaccine genes. Prior immunity can blunt a vaccine built on it.
The team compared muscle, nose, and oral delivery routes in mice. The vaccine expressed an Ebola surface protein for the tests. Nasal delivery bypassed the pre-existing immunity problem. It also improved the immune response over other routes. The nose route also avoids needles, which could help mass vaccine drives.
Catalog record
| CREATOR | Maria A. Croyle, Ami Patel, Kaylie N. Tran et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003548